Search Results - "El Moghrabi, Soumaya"

Refine Results
  1. 1

    The Bone Morphogenetic Protein Signaling Inhibitor LDN-193189 Enhances Metastasis Development in Mice by Vollaire, Julien, Machuca-Gayet, Irma, Lavaud, Jonathan, Bellanger, Aurélie, Bouazza, Lamia, El Moghrabi, Soumaya, Treilleux, Isabelle, Coll, Jean-Luc, Peyruchaud, Olivier, Josserand, Véronique, Cohen, Pascale A

    Published in Frontiers in pharmacology (19-06-2019)
    “…Breast cancer with bone metastasis is essentially incurable with current anticancer therapies. The bone morphogenetic protein (BMP) pathway is an attractive…”
    Get full text
    Journal Article
  2. 2

    The diuretic torasemide does not prevent aldosterone-mediated mineralocorticoid receptor activation in cardiomyocytes by Gravez, Basile, Tarjus, Antoine, Jimenez-Canino, Ruben, El Moghrabi, Soumaya, Messaoudi, Smail, Alvarez de la Rosa, Diego, Jaisser, Frederic

    Published in PloS one (09-09-2013)
    “…Aldosterone binds to the mineralocorticoid receptor (MR) and exerts pleiotropic effects beyond enhancing renal sodium reabsorption. Excessive mineralocorticoid…”
    Get full text
    Journal Article
  3. 3

    Tissue kallikrein permits early renal adaptation to potassium load by Moghrabi, Soumaya El, Houillier, Pascal, Picard, Nicolas, Sohet, Fabien, Wootla, Bharath, Bloch-Faure, May, Leviel, Françoise, Cheval, Lydie, Frische, Sebastian, Meneton, Pierre, Eladari, Dominique, Chambrey, Régine, Giebisch, Gerhard

    “…Tissue kallikrein (TK) is a serine protease synthetized in renal tubular cells located upstream from the collecting duct where renal potassium balance is…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Smooth Muscle Cell Mineralocorticoid Receptors Are Mandatory for Aldosterone–Salt to Induce Vascular Stiffness by Galmiche, Guillaume, Pizard, Anne, Gueret, Alexandre, El Moghrabi, Soumaya, Ouvrard-Pascaud, Antoine, Berger, Stefan, Challande, Pascal, Jaffe, Iris Z., Labat, Carlos, Lacolley, Patrick, Jaisser, Frédéric

    Published in Hypertension (Dallas, Tex. 1979) (01-03-2014)
    “…Arterial stiffness is recognized as a risk factor for many cardiovascular diseases. Aldosterone via its binding to and activation of the mineralocorticoid…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Role of smooth muscle cell mineralocorticoid receptor in vascular tone by Tarjus, Antoine, Belozertseva, Ekaterina, Louis, Huguette, El Moghrabi, Soumaya, Labat, Carlos, Lacolley, Patrick, Jaisser, Frédéric, Galmiche, Guillaume

    Published in Pflügers Archiv (01-08-2015)
    “…Identification of the mineralocorticoid receptor (MR) in the vasculature (i.e., endothelial and smooth muscle cells) raised the question of its role in…”
    Get full text
    Journal Article
  10. 10

    The Mineralocorticoid Receptor on Smooth Muscle Cells Promotes Tacrolimus-Induced Renal Injury in Mice by Figueroa, Stefanny M, Bertocchio, Jean-Philippe, Nakamura, Toshifumi, El-Moghrabi, Soumaya, Jaisser, Frédéric, Amador, Cristián A

    Published in Pharmaceutics (29-04-2023)
    “…Tacrolimus (Tac) is a calcineurin inhibitor commonly used as an immunosuppressor after solid organ transplantation. However, Tac may induce hypertension,…”
    Get full text
    Journal Article
  11. 11

    Defective ENaC Processing and Function in Tissue Kallikrein-deficient Mice by Picard, Nicolas, Eladari, Dominique, El Moghrabi, Soumaya, Planès, Carole, Bourgeois, Soline, Houillier, Pascal, Wang, Qing, Burnier, Michel, Deschenes, Georges, Knepper, Mark A., Meneton, Pierre, Chambrey, Régine

    Published in The Journal of biological chemistry (22-02-2008)
    “…An inverse relationship exists between urinary tissue kallikrein (TK) excretion and blood pressure in humans and rodents. In the kidney TK is synthesized in…”
    Get full text
    Journal Article
  12. 12
  13. 13

    NGAL is a Novel Target in Hypertension by Modulating the NCC-Mediated Renal Na Balance by Bonnard, Benjamin, El Moghrabi, Soumaya, Ueda, Kohei, Lattenist, Lionel, Soulie, Matthieu, López-Andrés, Natalia, Xhaard, Constance, Shimosawa, Tatsuo, Rossignol, Patrick, Jaisser, Frédéric

    Published in Hypertension (Dallas, Tex. 1979) (01-09-2023)
    “…The expression of NGAL/lcn2 (neutrophil gelatinase-associated lipocalin) is directly modulated by mineralocorticoid receptor activation but its role in blood…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Sulfenic Acid Modification of Endothelin B Receptor is Responsible for the Benefit of a Nonsteroidal Mineralocorticoid Receptor Antagonist in Renal Ischemia by Barrera-Chimal, Jonatan, Prince, Sonia, Fadel, Fouad, El Moghrabi, Soumaya, Warnock, David G, Kolkhof, Peter, Jaisser, Frédéric

    “…AKI is associated with high mortality rates and the development of CKD. Ischemia/reperfusion (IR) is an important cause of AKI. Unfortunately, there is no…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Abstract P298: Finerenone Protects Against the Acute and Chronic Consequences of Renal Ischemia/reperfusion Injury by Barrera-Chimal, Jonatan, Le Mercier, Alan, El-Moghrabi, Soumaya, Kolkhof, Peter, Jaisser, Frederic

    Published in Hypertension (Dallas, Tex. 1979) (01-09-2016)
    “…Abstract only Introduction: One of the most common causes of acute kidney injury (AKI) is renal ischemia/reperfusion (IR). Mineralocorticoid receptor (MR)…”
    Get full text
    Journal Article
  20. 20